氯丙那林结构式
|
常用名 | 氯丙那林 | 英文名 | Clorprenaline |
|---|---|---|---|---|
| CAS号 | 3811-25-4 | 分子量 | 213.704 | |
| 密度 | 1.1±0.1 g/cm3 | 沸点 | 329.7±27.0 °C at 760 mmHg | |
| 分子式 | C11H16ClNO | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 153.2±23.7 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
氯丙那林用途氯丙瑞林是β2-肾上腺素能受体激动剂。氯丙瑞林促进动物肌肉的生长,减少脂肪的积累。Clorprenaline是一种潜在的新型瘦肉增强饲料添加剂[1]。 |
| 中文名 | 氯丙那林 |
|---|---|
| 英文名 | 1-(2-chlorophenyl)-2-(propan-2-ylamino)ethanol |
| 中文别名 | 氯喘通 | alpha-[1-(甲基乙基)氨基甲基]-2-氯-苯甲醇 | 1-(2-氯苯基)-2-异丙基氨基-乙醇 |
| 英文别名 | 更多 |
| 描述 | 氯丙瑞林是β2-肾上腺素能受体激动剂。氯丙瑞林促进动物肌肉的生长,减少脂肪的积累。Clorprenaline是一种潜在的新型瘦肉增强饲料添加剂[1]。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
β2-adrenergic[1] |
| 参考文献 |
| 密度 | 1.1±0.1 g/cm3 |
|---|---|
| 沸点 | 329.7±27.0 °C at 760 mmHg |
| 分子式 | C11H16ClNO |
| 分子量 | 213.704 |
| 闪点 | 153.2±23.7 °C |
| 精确质量 | 213.092041 |
| PSA | 32.26000 |
| LogP | 2.18 |
| InChIKey | SSMSBSWKLKKXGG-UHFFFAOYSA-N |
| SMILES | CC(C)NCC(O)c1ccccc1Cl |
| 蒸汽压 | 0.0±0.8 mmHg at 25°C |
| 折射率 | 1.537 |
| 储存条件 | 室温,干燥,密封 |
|
~%
氯丙那林 3811-25-4 |
| 文献:E.Lilly and Co. Patent: US2887509 , 1956 ; |
| 氯丙那林上游产品 1 | |
|---|---|
| 氯丙那林下游产品 0 | |
| 海关编码 | 2922199090 |
|---|---|
| 中文概述 | 2922199090. 其他氨基醇及其醚,酯和它们的盐(但含一种以上含氧基的除外). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
| Summary | 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis.
Electrophoresis 29(11) , 2321-9, (2008) The analysis is described for separating seven beta-adrenergic blocking agents (atenolol, celiprolol, clorprenaline, fenoterol, metoprolol, propranolol, terbutaline) and clenbuterol (sympathomimetic b... |
|
|
[Studies on sustained-release dosage forms for clorprenaline pamoate].
Yao Xue Xue Bao 17(6) , 469-71, (1982)
|
|
|
[Simultaneous determination of three components in compound clorprenaline tablet by using the derivative-complementary tristimulus method].
Yao Xue Xue Bao 25(5) , 357-61, (1990) Clorprenaline hydrochloride (a), bromhexine hydrochloride (b) and decloxizine hydrochloride (c) are three main components in clorprenaline compound tablet. The serious overlapping bands of their absor... |
| Isoprophenamine |
| Clorprenaline HCl |
| 1-(2-chlorophenyl)-2-(propan-2-ylamino)ethanol |
| Clorprenalinum |
| Chlorprenalin |
| Isoprophenamine (VAN) |
| Isoprophenamin |
| 2-Chloro-a-[[(1-methylethyl)amino]methyl]benzenemethanol |
| 1-(2-Chlorophenyl)-2-(isopropylamino)ethanol |
| o-Chloro-α-((isopropylamino)methyl)benzyl alcohol |
| EINECS 223-291-8 |
| MFCD00864144 |
| isoprofenamine |
| 1-(o-Chlorophenyl)-2-isopropylaminoethanol |
| clorprenaline |
| N-(b-o-Chlorophenyl-b-hydroxyethyl)isopropylamine |
| Clorprenalina |
| o-Chloro-a-(isopropylaminomethyl)benzyl Alcohol |